ALK News Releases https://ir.alk.net/ ALK News Releases en ALK obtains European approval for its tree SLIT-tablet against allergic rhinitis https://ir.alk.net/news-releases/news-release-details/alk-obtains-european-approval-its-tree-slit-tablet-against ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that it has successfully completed the marketing authorisation procedure for its tree sublingual allergy immunotherapy (SLIT) tablet in 17 European countries. ITULAZAX ® is expected to be the brand name of the tree SLIT-tablet. Fri, 07 Jun 2019 08:57:13 -0400 ALK News Releases 17601 As ALK prepares to further extend their SLIT-tablet portfolio, tablet formulation is seen as key in delivering consistent positive clinical trial results https://ir.alk.net/news-releases/news-release-details/alk-prepares-further-extend-their-slit-tablet-portfolio-tablet Zydis ® freeze-dried tablet technology used in ALK’s SLIT-tablet range makes them faster dissolving than conventional compressed sublingual tablets in in-vitro testing. Resulting in rapid and predictable release of the active ingredient contained in the ALK SLIT-tablets. Tue, 04 Jun 2019 03:31:10 -0400 ALK News Releases 17596 Targeted early treatment with ALK’s ACARIZAX® could improve allergic asthma treatment, allergy congress hears https://ir.alk.net/news-releases/news-release-details/targeted-early-treatment-alks-acarizaxr-could-improve-allergic Easy to measure biomarkers could identify a group of patients who benefit even more from ACARIZAX ® treatment of house dust mite (HDM)-induced allergic asthma Early identification of patients would allow earlier treatment intervention With its HDM SLIT-tablet, ALK is well-placed to lead the way on Mon, 03 Jun 2019 07:49:24 -0400 ALK News Releases 17591 Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff https://ir.alk.net/news-releases/news-release-details/report-transactions-alk-abello-b-shares-and-associated-5 ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) reports the following transactions: 1. Details of the person discharging managerial responsibility / person closely associated a) Name Henrik Jacobi 2. Reason for the notification a) Position/status Member of the Board of Management b) Initial Mon, 13 May 2019 11:29:49 -0400 ALK News Releases 17576 Three-month interim report (Q1) 2019 https://ir.alk.net/news-releases/news-release-details/three-month-interim-report-q1-2019 Strong sales growth in Q1 (unaudited) In Q1, ALK had organic growth of 14% and continued to deliver on its growth strategy, which saw accelerated growth in tablet sales of 52% and further stabilisation of its legacy AIT business. Other products also performed well and growth was broad-based across Thu, 09 May 2019 01:30:46 -0400 ALK News Releases 17556 Release date of three-month interim report 2019 for ALK and audio cast https://ir.alk.net/news-releases/news-release-details/release-date-three-month-interim-report-2019-alk-and-audio-cast On Thursday, 9 May 2019, ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) releases its three-month interim report 2019. ALK will host a meeting for analysts and institutional investors that day at 13.30 p.m. (CEST) at which Management will review the financial results, the outlook and answer questions. Thu, 02 May 2019 03:40:19 -0400 ALK News Releases 17541 Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff https://ir.alk.net/news-releases/news-release-details/report-transactions-alk-abello-b-shares-and-associated-4 ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following transactions under securities identification code (ISIN) DK0060027142 / LEI code: Thu, 21 Mar 2019 12:05:47 -0400 ALK News Releases 17511 Grant of share options and performance shares to members of the Board of Management and key employees https://ir.alk.net/news-releases/news-release-details/grant-share-options-and-performance-shares-members-board-0 ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ): Share option programme According to the guidelines for incentive payments adopted at the Company's annual general meeting on 13 March 2019, the Board of Directors has passed a resolution to grant a total of 25,392 share options, comprising 13,229 Thu, 21 Mar 2019 11:57:26 -0400 ALK News Releases 17506 Annual General Meeting in ALK-Abelló A/S held on 13 March 2019 https://ir.alk.net/news-releases/news-release-details/annual-general-meeting-alk-abello-held-13-march-2019 ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) held its annual general meeting on 13 March 2019. The annual general meeting transacted the following business: Adoption of the annual report 2018 and discharge of the Board of Directors and Board of Management. No declaration of ordinary dividend. Wed, 13 Mar 2019 12:13:56 -0400 ALK News Releases 17496 The pollen season kicks off with an award-winning pollen app https://ir.alk.net/news-releases/news-release-details/pollen-season-kicks-award-winning-pollen-app If you are one of the estimated 5 million in the UK   who sneeze and sniffle their way through the pollen season, then help is at hand. A personalised allergy app detailing location-based pollen counts and real-time air quality is here to help people better manage their allergy. Tue, 12 Mar 2019 04:58:09 -0400 ALK News Releases 17476